KyDo Therapeutics
Dortmund
About KyDo Therapeutics
KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.3M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: kydo-tx.com
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/kydo-therapeutics-40393 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.